筛查时腹主动脉下段直径较小的男性中腹主动脉瘤进展的预测因素
在瑞典马尔默筛查中腹主动脉直径25-29 mm的男性队列(n=270,中位随访9.9年)中,基于体表面积的相对动脉瘤标准可识别生长更快、达到40 mm时间更短者,但差异可能过小,尚不足以改变临床实践,需进一步研究确定临床意义。
要点
- 相对动脉瘤组生长率增加0.4 mm/年(95%CI 0.0-0.7),吸烟者增加0.4 mm/年(95%CI 0.2-0.7)。
- 相对动脉瘤组达到直径≥40 mm的风险比为2.77(95%CI 1.34-5.74;P=.006)。
- 作者认为差异可能过小,不足以改变临床实践,需进一步研究确定临床意义。
核心结论
- 在筛查时腹主动脉直径25-29 mm的男性中,基于身高和体重的个体化诊断标准可识别动脉瘤生长更快、达到40 mm时间更短者。
- 相对主动脉直径似乎对动脉瘤发展重要,但差异可能过小,不足以改变临床实践,需进一步研究确定临床意义。
研究设计与样本
- 在瑞典马尔默腹主动脉瘤筛查中腹主动脉直径25-29 mm的男性队列研究,中位随访9.9年,共270人。
- 采用线性混合效应模型比较相对动脉瘤组与非相对动脉瘤组的生长率,并用log-rank检验和Cox比例风险模型评估达到40 mm的时间与风险比,均校正吸烟状态和糖尿病。
主要发现
- 队列270人中3人发展为腹主动脉瘤≥55 mm。
- 基线生长率为0.1 mm/年(95%CI 0.0-0.3)。
- 相对动脉瘤组生长率增加0.4 mm/年(95%CI 0.0-0.7),吸烟者增加0.4 mm/年(95%CI 0.2-0.7)。
- 相对动脉瘤组达到腹主动脉下段直径≥40 mm的中位时间为11.5年,非相对动脉瘤组未达到,按吸烟分层的log-rank检验差异显著(P=.009)。
- 相对动脉瘤组达到腹主动脉下段直径≥40 mm的风险比为2.77(95%CI 1.34-5.74;P=.006)。
关键数值与推荐
- 相对动脉瘤定义为腹主动脉下段直径≥预期直径的150%,预期直径以体表面积作为缩放因子计算。
- 绝对腹主动脉瘤定义为腹主动脉下段直径≥30 mm。
临床怎么用
- 作者认为相对主动脉直径似乎对动脉瘤发展重要,但差异可能过小,不足以改变临床实践,需进一步研究确定临床意义。
局限性
- 作者指出差异可能过小,不足以改变临床实践,需进一步研究确定临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Screening for abdominal aortic aneurysm (AAA) defined as an infrarenal aortic diameter (IAD) of ≥30 mm reduces mortality, but managing patients with diameters of 25 to 29 mm is debated. Incorporating body surface area into the diagnostic criteria may improve the identification of those at risk of developing treatment-requiring aneurysms in this group. In a previous study, we defined a relative AAA as an IAD ≥150% larger than expected, with the normal diameter calculated using body surface area as a scaling factor. This study aimed to determine if this criterion could identify those at risk of aneurysmal development among patients with aortic diameter of 25 to 29 mm at screening. METHODS: A cohort study was conducted on men with abdominal aortic diameters of 25 to 29 mm at AAA screening in Malmö, Sweden, with a median follow-up of 9.9 years. Growth rates were compared between the relative aneurysm group and the nonrelative aneurysm group using a linear mixed-effects model to account for both fixed and random effects. Time and hazard ratio to reach 40 mm, a marker of significant aneurysmal progression, were assessed using a log-rank test and a Cox proportional hazards model, both adjusted for smoking status and diabetes. RESULTS: In a cohort of 270 men, three developed AAAs ≥55 mm. The baseline growth rate was 0.1 mm/year (95% confidence interval [CI], 0.0-0.3). Growth rates were increased by 0.4 mm/year (95% CI, 0.0-0.7) in the relative aneurysm group, and by 0.4 mm/year (95% CI, 0.2-0.7) in smokers. The median time to reach an IAD of ≥40 mm was 11.5 years for relative aneurysms and was not reached for those without, with a significant difference shown by a log-rank test stratified for smoking (P = .009). Hazards ratio to reach an IAD of ≥40 mm for relative aneurysms was 2.77 (95% CI, 1.34-5.74; P = .006) compared with those without. CONCLUSIONS: In men with diameters of 25 to 29 mm at screening for AAAs, the use of an individualized diagnostic criterion, based on height and weight, could identify those with increased aneurysm growth and a significantly shorter time to reach 40 mm compared with baseline. The relative aortic diameter, beyond the absolute diameter, seemed to be important for aneurysmal development. However, the differences were likely too small to warrant changes in clinical practice, highlighting the need for further research to establish clinical relevance.
引用
- Starck J, Brunkwall S, Lundgren F, et al. Predictors of abdominal aortic aneurysm progression in men with small infrarenal aortic diameters at screening. J Vasc Surg. 2025. PMID: 39914757. doi:10.1016/j.jvs.2025.01.214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。